CTS13 - COVID-19 in China

Speaker(s)

• RB

  Richard Brostrom

  Hawaii State Department Of Health

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• FW

  Fusheng Wang

  The Fifth Medical Center of PLA General Hospital

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Gui-Qiang (John) Wang, MD

  Professor, Chairman, Department of Infectious Diseases
  Peking University First Hospital
  Beijing, Beijing, China (People's Republic)

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LZ

  Lei Zhou

  Chinese Center for Disease Control and Pevention

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of hours of MOC Credit

No CPE Credits

Learning Objectives:

• discuss the diagnosis and treatment responses to COVID-19 in China
• discuss the pathogenesis and pathology of COVID-19 in China
• discuss the prevention and infection control response to COVID-19 in China

Presentations:

• 11:30pm – 1:30am EDT

  COVID-19 in the US Pacific Islands: Preventing and Preparing
  Richard Brostrom – Hawaii State Department Of Health
• 11:30pm – 1:30am EDT

  Diagnosis and Treatment of COVID-19 in China
  Fusheng Wang – The Fifth Medical Center of PLA General Hospital
• 11:30pm – 1:30am EDT

  Pathogenesis and Pathology of COVID-19
  Gui-Qiang (John) Wang, MD – Peking University First Hospital
• 11:30pm – 1:30am EDT

  Prevention and Control of COVID-19 in China
  Lei Zhou – Chinese Center for Disease Control and Pevention